My research interest is focused on the role of nuclear receptor (NURR1) in neuroinflammation. Nuclear receptors in addition to their role as transcriptional activators, are able to suppress the expression of inflammatory genes and promote the resolution of inflammation. I am studying the role of NURR1 in activated immune cells such as microglia. I am particularly interested in anti-inflammatory drug development using nanotechnology, in terms of modifying nuclear receptor activity. My lab is also focused on the state-of-the-art for anticancer drug development based on siRNAs technology. Our research devoted to presenting current connections between experimental and in silico approaches for therapies based on siRNA delivery, accounting for all the most promising techniques based on liposomes, nanoparticles and so on. Our anticancer research also goes with the hottest trend in utilizing autophagy as a cellular tool for targeting different cancer types, believing that manipulating autophagy may possess a potential target that may deal differently with different cancer types.